About
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Through our core commitments, we are leveraging our scale for the greater good, such as serving the needs of our stakeholders, donating back to our communities, protecting our planet, working with policymakers, and more.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportOur businesses bring together leading technologies, innovative solutions and hands-on expertise to support the entire healthcare ecosystem.
We distribute pharmaceuticals and medical supplies to healthcare settings across North America, from pharmacies and hospitals to doctors’ offices and clinics.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
We provide research, insights, technologies and other support to help address challenges in cancer and specialty care.
We provide a suite of solutions designed to address access, affordability and adherence challenges by bridging the gaps between biopharma companies, pharmacies, providers, and payers to help patients get on and stay on their medications.
We offer solutions that enable employers, payers, health-plan brokers and government agencies to provide lower-cost options for prescription medications and therapies.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportDear Customer,
McKesson continues to serve customers across all our lines of business and accept orders. Our distribution centers remain operational, and we continue to ship products across our distribution network.
Based on our investigation thus far, including assessments by leading cybersecurity industry experts supporting our response, we’ve confirmed that the unauthorized access to certain third-party applications and the exfiltration of certain data was associated with a subset of customers within our Oncology & Multispecialty and Medical-Surgical business units.
We have reasonable assurance of no ongoing unauthorized activity in our systems. Customers can continue to connect to and use our systems and services as intended.
We continue to monitor our environment closely and take measures to support the security and reliability of our operations.
In terms of next steps:
We take the security and privacy of our partners, customers and their patients very seriously. We appreciate your patience and partnership as our investigation continues.
Respectfully,
Francisco Fraga
Executive Vice President, Chief Information Officer and Chief Technology Officer
AUGUST 28, 2026
Dear Customer,
McKesson is in the early stages of investigating a cybersecurity incident involving third-party applications and unauthorized access and exfiltration of data.
We take the security and privacy of our partners, customers and their patients very seriously. Upon discovery, we immediately activated our incident response protocols, launched an investigation, and engaged leading cybersecurity industry experts to assist in our response.
Our investigation remains ongoing, and we are working to fully ascertain the nature and scope of the incident so that we can provide accurate and concrete information as it becomes available.
Our cybersecurity team and leading cybersecurity industry experts are working to minimize the impact on system availability and business operations. At this time, customers may experience intermittent service degradation that we believe may be related to this incident. We are aware of these issues and continue to monitor the situation closely.
Based on the information currently available, we do not believe any action is required by our customers and we are not proactively disconnecting systems within our environment at this time. If you encounter technical issues with our services, please contact us through your normal support channels.
We understand you have questions regarding this incident. Our team is focused on developing a more complete understanding of the situation. We remain committed to keeping you informed and will continue to provide updates.
We appreciate your patience and partnership as our investigation continues.
Respectfully,
Francisco Fraga
Executive Vice President, Chief Information Officer and Chief Technology Officer